Optiscan Imaging Ltd Total Liabilities
Optiscan Imaging Ltd total liabilities. Based on the latest financial reports, Optiscan Imaging Ltd (OIL) has total liabilities worth AU$2.93 Million AUD (≈ $2.07 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Optiscan Imaging Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Optiscan Imaging Ltd (1998–2025)
Total liabilities of Optiscan Imaging Ltd from 1998 to 2025. This chart illustrates how Optiscan Imaging Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Optiscan Imaging Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Optiscan Imaging Ltd Competitors by Total Liabilities
The table below lists competitors of Optiscan Imaging Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Air Busan Co Ltd
KO:298690
|
Korea | ₩1.29 Trillion |
|
MFS High Income Municipal Closed Fund
NYSE:CXE
|
USA | $83.53 Million |
|
Genovate Biotechnology Co Ltd
TWO:4130
|
Taiwan | NT$126.05 Million |
|
Kamdhenu Limited
NSE:KAMDHENU
|
India | Rs531.83 Million |
|
Digimarc Corporation
NASDAQ:DMRC
|
USA | $16.40 Million |
|
KUB Malaysia Bhd
KLSE:6874
|
Malaysia | RM244.93 Million |
|
Tribeca Global Natural Resources Ltd
AU:TGF
|
Australia | AU$68.42 Million |
|
Complete Solaria, Inc. Common Stock
NASDAQ:CSLR
|
USA | $270.32 Million |
Liability Composition Analysis (1998–2025)
This chart breaks down Optiscan Imaging Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Optiscan Imaging Ltd balance sheet assets.
Liquidity & Leverage Metrics
Optiscan Imaging Ltd Total Liabilities Ratios Explained
Optiscan Imaging Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 14.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 10.71 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Optiscan Imaging Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Optiscan Imaging Ltd (1998–2025)
The table below shows the annual total liabilities of Optiscan Imaging Ltd from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$2.84 Million ≈ $2.01 Million |
+61.32% |
| 2024-06-30 | AU$1.76 Million ≈ $1.25 Million |
+8.29% |
| 2023-06-30 | AU$1.63 Million ≈ $1.15 Million |
+16.95% |
| 2022-06-30 | AU$1.39 Million ≈ $984.71K |
-5.94% |
| 2021-06-30 | AU$1.48 Million ≈ $1.05 Million |
-21.99% |
| 2020-06-30 | AU$1.90 Million ≈ $1.34 Million |
+131.11% |
| 2019-06-30 | AU$820.64K ≈ $580.66K |
-11.63% |
| 2018-06-30 | AU$928.69K ≈ $657.11K |
-7.26% |
| 2017-06-30 | AU$1.00 Million ≈ $708.53K |
-61.04% |
| 2016-06-30 | AU$2.57 Million ≈ $1.82 Million |
+115.39% |
| 2015-06-30 | AU$1.19 Million ≈ $844.42K |
+19.22% |
| 2014-06-30 | AU$1.00 Million ≈ $708.28K |
+79.40% |
| 2013-06-30 | AU$557.98K ≈ $394.80K |
-35.67% |
| 2012-06-30 | AU$867.36K ≈ $613.71K |
+1.22% |
| 2011-06-30 | AU$856.94K ≈ $606.34K |
-3.95% |
| 2010-06-30 | AU$892.14K ≈ $631.25K |
-20.29% |
| 2009-06-30 | AU$1.12 Million ≈ $791.93K |
-26.68% |
| 2008-06-30 | AU$1.53 Million ≈ $1.08 Million |
-8.65% |
| 2007-06-30 | AU$1.67 Million ≈ $1.18 Million |
+0.41% |
| 2006-06-30 | AU$1.66 Million ≈ $1.18 Million |
+60.39% |
| 2005-06-30 | AU$1.04 Million ≈ $734.23K |
+27.24% |
| 2004-06-30 | AU$815.54K ≈ $577.05K |
-73.98% |
| 2003-06-30 | AU$3.13 Million ≈ $2.22 Million |
+28.09% |
| 2002-06-30 | AU$2.45 Million ≈ $1.73 Million |
+416.59% |
| 2001-06-30 | AU$473.66K ≈ $335.14K |
-37.72% |
| 2000-06-30 | AU$760.54K ≈ $538.13K |
-33.39% |
| 1999-06-30 | AU$1.14 Million ≈ $807.92K |
+73.17% |
| 1998-06-30 | AU$659.36K ≈ $466.54K |
-- |
About Optiscan Imaging Ltd
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows;… Read more